We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$23.4B
AUM Growth
-$645M
Cap. Flow
-$927M
Cap. Flow %
-3.96%
Top 10 Hldgs %
14.43%
Holding
1,543
New
166
Increased
513
Reduced
496
Closed
116

Top Buys

Rank Stock Value
1
F icon
Ford
F
+$134M
2
PRU icon
Prudential Financial
PRU
+$68.1M
3
ETR icon
Entergy
ETR
+$53.9M
4
CIT
CIT Group Inc.
CIT
+$45.3M
5
BFH icon
Bread Financial
BFH
+$38.9M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$107M
2
PPG icon
PPG Industries
PPG
+$92.5M
3
DB icon
Deutsche Bank
DB
+$90M
4
BKNG icon
Booking.com
BKNG
+$75.1M
5
VZ icon
Verizon
VZ
+$66.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16%
2 Technology 14.48%
3 Financials 13.49%
4 Industrials 10.4%
5 Energy 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
151
Consolidated Edison
ED
$41.2B
$44.8M 0.19%
789,867
-514,610
-39% -$29.2M
LNC icon
152
Lincoln National
LNC
$8.06B
$44.2M 0.19%
825,541
+48,700
+6% +$2.59M
PFG icon
153
Principal Financial Group
PFG
$24.6B
$44M 0.19%
839,000
+72,270
+9% +$3.78M
REGN icon
154
Regeneron Pharmaceuticals
REGN
$72.9B
$43.6M 0.19%
120,916
+75,523
+166% +$25.3M
NKE icon
155
Nike
NKE
$64.7B
$43.4M 0.19%
972,156
+327,354
+51% +$13M
SCG
156
DELISTED
Scana
SCG
$43M 0.18%
866,719
-12,390
-1% -$635K
LYB icon
157
LyondellBasell Industries
LYB
$19.7B
$42.9M 0.18%
394,396
+99,520
+34% +$10.8M
MO icon
158
Altria Group
MO
$125B
$42.3M 0.18%
920,758
+102,600
+13% +$4.39M
GWW icon
159
W.W. Grainger
GWW
$65B
$42.1M 0.18%
167,188
-47,425
-22% -$11.6M
VRTX icon
160
Vertex Pharmaceuticals
VRTX
$124B
$41.1M 0.18%
366,102
+7,747
+2% +$738K
ABT icon
161
Abbott
ABT
$188B
$40.7M 0.17%
979,652
+527,118
+116% +$22.3M
AGN
162
DELISTED
Allergan plc
AGN
$40.3M 0.17%
167,146
+75,482
+82% +$16.9M
SU icon
163
Suncor Energy
SU
$77.7B
$40.2M 0.17%
1,108,240
+66,136
+6% +$2.65M
MAN icon
164
ManpowerGroup
MAN
$2.63B
$40.1M 0.17%
571,650
+20,000
+4% +$1.56M
MCK icon
165
McKesson
MCK
$105B
$40M 0.17%
205,547
-176
-0.1% -$33.9K
VLO icon
166
Valero Energy
VLO
$90.4B
$39.5M 0.17%
853,945
+12,746
+2% +$643K
CL icon
167
Colgate-Palmolive
CL
$74.6B
$38.8M 0.17%
594,419
+2,293
+0.4% +$151K
MA icon
168
Mastercard
MA
$500B
$38.3M 0.16%
518,388
-67,047
-11% -$5.11M
MRVL icon
169
Marvell Technology
MRVL
$157B
$37.4M 0.16%
2,771,770
+311,970
+13% +$4.3M
IGM icon
170
iShares Expanded Tech Sector ETF
IGM
$9.86B
$36.6M 0.16%
2,243,700
CAT icon
171
Caterpillar
CAT
$366B
$36.6M 0.16%
369,481
+10,364
+3% +$1.1M
CPA icon
172
Copa Holdings
CPA
$5.67B
$36.5M 0.16%
340,061
-12,661
-4% -$1.69M
CX icon
173
Cemex
CX
$17.2B
$36.3M 0.16%
3,127,296
-313,477
-9% -$3.64M
PNC icon
174
PNC Financial Services
PNC
$99.5B
$36.2M 0.15%
422,476
-78,530
-16% -$6.68M
R icon
175
Ryder
R
$9.99B
$36.1M 0.15%
401,765
-122,563
-23% -$11M

Similar funds

Axa's Q3 2014 Portfolio in Review

As of Q3 2014, Axa held 1,543 positions worth $23.4B, down 2.7% from $24B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $927M in Q3 2014, closing 116 positions and reducing 496 holdings. Its most notable exit was Bunge Global, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Axa opened a new position in CYTEC INDS INC worth $21.7M.

  • Axa's largest Q3 2014 buy was CYTEC INDS INC: 458,648 shares worth $21.7M.
  • Axa added most to Ford in Q3 2014, an estimated $134M increase.
  • Axa's biggest Q3 2014 reduction was UnitedHealth, cutting an estimated $107M.
  • Axa fully exited Bunge Global in Q3 2014, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 14% of its $23.4B portfolio in Q3 2014.
  • Axa opened 166 new positions and closed 116 in Q3 2014.
  • Axa's portfolio value fell 2.7% quarter-over-quarter to $23.4B.

Based on Axa's 13F filing for Q3 2014, filed 13 Nov 2014.